Bloom Burton Securities
Tracked across 3 events · 21 articles · First seen May 28, 2026 · Last active Jun 10, 2026
Live sentiment trends, attention charts, and prominence tracking available on the
NewsDesk Dashboard
Business
Medicenna Therapeutics Corp., a clinical-stage immunotherapy company, announced the closing of its public offering, raising approximately CDN$4.44 million. The offering involved the issuance of 8,880,000 units at CDN$0.50 per unit, each comprising one common share…
Impact: Bloom Burton Securities acted as the sole agent for Medicenna Therapeutics' public offering, facilitating the raising of CDN$4.44 million and receiving compensation warrants.
May 28, 2026 · 6 articles
Business
Thiogenesis Therapeutics Corporation, a clinical-stage biotechnology company, successfully completed an oversubscribed non-brokered private placement, raising gross proceeds of C$9,071,850. The company issued 18,143,700 common shares at C$0.50 per share. The funds will primarily be used…
Impact: Bloom Burton Securities acted as a financial and strategic advisor to Thiogenesis Therapeutics Corporation for the private placement, receiving a C$50,000 fee for its services.
Jun 01, 2026 · 6 articles
Business
Apotex, a Canadian-based global health company, has successfully launched and priced its upsized initial public offering (IPO). The company initially filed a preliminary prospectus on May 28, 2026, and officially launched its IPO on June…
Impact: Bloom Burton Securities Inc. is a co-manager for Apotex's IPO.
May 28, 2026 · 9 articles
70
Medicenna Therapeutics issued compensation warrants Bloom Burton SecuritiesMedicenna Closes CDN$4.44M...
40
Thiogenesis Therapeutics Corporation engaged as advisor Bloom Burton SecuritiesThiogenesis Therapeutics...
NEWSDESK
Track Bloom Burton Securities live
Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.
Open Dashboard